EE200200168A - PRV-1-geen ja selle kasutamine - Google Patents

PRV-1-geen ja selle kasutamine

Info

Publication number
EE200200168A
EE200200168A EEP200200168A EEP200200168A EE200200168A EE 200200168 A EE200200168 A EE 200200168A EE P200200168 A EEP200200168 A EE P200200168A EE P200200168 A EEP200200168 A EE P200200168A EE 200200168 A EE200200168 A EE 200200168A
Authority
EE
Estonia
Prior art keywords
prv
gene
Prior art date
Application number
EEP200200168A
Other languages
English (en)
Estonian (et)
Inventor
Pahl Heike
Original Assignee
Universittsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universittsklinikum Freiburg filed Critical Universittsklinikum Freiburg
Publication of EE200200168A publication Critical patent/EE200200168A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EEP200200168A 1999-09-30 2000-09-29 PRV-1-geen ja selle kasutamine EE200200168A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (de) 1999-09-30 2000-09-29 Das gen prv-1 und dessen verwendung

Publications (1)

Publication Number Publication Date
EE200200168A true EE200200168A (et) 2003-04-15

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200168A EE200200168A (et) 1999-09-30 2000-09-29 PRV-1-geen ja selle kasutamine

Country Status (21)

Country Link
EP (1) EP1220920A1 (xx)
JP (1) JP2003510077A (xx)
KR (1) KR20020047191A (xx)
CN (1) CN1377408A (xx)
AU (1) AU1132401A (xx)
BG (1) BG106554A (xx)
BR (1) BR0014444A (xx)
CA (1) CA2387702A1 (xx)
CZ (1) CZ20021094A3 (xx)
DE (1) DE19947010A1 (xx)
EA (1) EA200200286A1 (xx)
EE (1) EE200200168A (xx)
HR (1) HRP20020269A2 (xx)
HU (1) HUP0203080A2 (xx)
IL (1) IL148770A0 (xx)
MX (1) MXPA02002800A (xx)
NO (1) NO20021498L (xx)
PL (1) PL354184A1 (xx)
SK (1) SK4262002A3 (xx)
WO (1) WO2001023554A1 (xx)
ZA (1) ZA200202379B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
KR102031317B1 (ko) 2012-05-21 2019-10-14 제넨테크, 인크. 혈액-뇌 장벽 수송의 안전성을 개선하는 방법
CN111094547B (zh) * 2017-06-14 2024-02-09 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） 用于纯化源自人胚胎干细胞的内胚层和胰腺内胚层细胞的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same
CA2289118A1 (en) * 1997-05-06 1998-11-12 Zymogenetics, Inc. Novel tumor antigens
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
MXPA01006057A (es) * 1998-12-16 2003-09-10 Genentech Inc Polipeptidos secretados y transmembranales y acidos nucleicos que los codifican.

Also Published As

Publication number Publication date
AU1132401A (en) 2001-04-30
BR0014444A (pt) 2002-06-11
KR20020047191A (ko) 2002-06-21
WO2001023554A1 (de) 2001-04-05
CA2387702A1 (en) 2001-04-05
CZ20021094A3 (cs) 2002-06-12
MXPA02002800A (es) 2002-07-22
NO20021498D0 (no) 2002-03-26
IL148770A0 (en) 2002-09-12
NO20021498L (no) 2002-05-23
BG106554A (bg) 2003-01-31
SK4262002A3 (en) 2002-09-10
HRP20020269A2 (en) 2003-06-30
ZA200202379B (en) 2003-10-29
CN1377408A (zh) 2002-10-30
DE19947010A1 (de) 2001-04-05
JP2003510077A (ja) 2003-03-18
PL354184A1 (en) 2003-12-29
HUP0203080A2 (hu) 2002-12-28
EA200200286A1 (ru) 2002-12-26
EP1220920A1 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
ID26056A (id) Popok sekali pakai
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
ID26389A (id) Popok sekali pakai
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
NO20022334L (no) Ny sammensetning og anvendelse
ID26599A (id) Turunan triazola dan imidazola
DE60039397D1 (de) Verdrehsicherung
FI20011671A0 (fi) Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
EE200200282A (et) Keemilised meetodid ja vaheühendid
ID24782A (id) Popok sekali pakai
ID25571A (id) Popok sekali pakai
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE60014955D1 (de) Schraubzange
NO20021604D0 (no) Leptin assay
EE200200096A (et) IREN-valk, selle valmistamine ja kasutamine
NO20021305L (no) DNA-konstruksjon og dens anvendelse
EE200200168A (et) PRV-1-geen ja selle kasutamine
ID25567A (id) Ulir-jepit dengan bahu-puntir
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
EE200000712A (et) Eeltäidetud süstal ja selle kasutamine
FI19992219A (fi) Yhdistetty difibrillaattori ja sydäntahdistin